Nexgel (NXGL) Accumulated Expenses (2018 - 2025)

Nexgel (NXGL) posted Accumulated Expenses of $460000.0 for Q4 2025, down 13.21% on a QoQ basis from $530000.0 in Q3 2025, and up 90.08% year-over-year from $242000.0 in Q4 2024.

Nexgel (NXGL) Accumulated Expenses (2018 - 2025) Analysis & Trends

Nexgel's Accumulated Expenses history runs 8 years deep, the most recent figure standing at $460000.0 for Q4 2025.

  • Quarterly Accumulated Expenses rose 90.08% year-over-year to $460000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $460000.0 (up 90.08% YoY) and the FY2025 annual result came in at $460000.0, up 90.08% from the prior year.
  • Accumulated Expenses was $460000.0 for Q4 2025 at Nexgel, down from $530000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $609000.0 in Q3 2024 and bottomed at $37000.0 in Q3 2023.
  • A 5-year average of $203800.0 and a median of $120500.0 in 2022 frame the typical range for Accumulated Expenses.
  • Annual changes were most pronounced in 2023 — Accumulated Expenses plunged 77.44% — and 2024, when it jumped 1545.95%.
  • Nexgel's Accumulated Expenses stood at $54000.0 in 2021, then soared by 140.74% to $130000.0 in 2022, then tumbled by 53.08% to $61000.0 in 2023, then surged by 296.72% to $242000.0 in 2024, then surged by 90.08% to $460000.0 in 2025.
  • Business Quant data shows NXGL's Accumulated Expenses at $460000.0 in Q4 2025, $530000.0 in Q3 2025, and $534000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn
10 Nexgel 3.50 Mn 2.13 Mn 819,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 460,000.00
Sep 30, 2025 530,000.00
Jun 30, 2025 534,000.00
Mar 31, 2025 249,000.00
Dec 31, 2024 242,000.00
Sep 30, 2024 609,000.00
Jun 30, 2024 284,000.00
Mar 31, 2024 111,000.00
Dec 31, 2023 61,000.00
Sep 30, 2023 37,000.00
Jun 30, 2023 202,000.00
Mar 31, 2023 38,000.00
Dec 31, 2022 130,000.00
Sep 30, 2022 164,000.00
Jun 30, 2022 78,000.00
Mar 31, 2022 57,000.00
Dec 31, 2021 54,000.00
Sep 30, 2021 77,000.00
Jun 30, 2021 70,000.00
Mar 31, 2021 89,000.00